Pharmacokinetics of vancomycin in sputum of intubated patients: Optimized intravenous delivery vs. inhaled therapy

Documenti analoghi

• External evaluation of intravenous vancomycin population pharmacokinetic models in adults receiving high‐flux intermittent haemodialysis
  di: Cheng Ji, et al.
  Pubblicazione: (2024)
• Pharmacokinetics and pharmacodynamics of intravenous and oral (S)‐ketamine: Investigating metabolite contribution to subjective effects
  di: Marije E. Otto, et al.
  Pubblicazione: (2026)
• Pharmacokinetics of the inactive favipiravir metabolite, favipiravir hydroxide (M1), as a proxy for establishing metabolic activity in patients receiving intravenous favipiravir for treatment of SARS‐CoV‐2 infection
  di: E. Challenger, et al.
  Pubblicazione: (2025)
• Pharmacokinetic modelling of intravenous immunoglobulin in children with primary immunodeficiencies and secondary antibody deficiencies
  di: Iek Leng Cheng, et al.
  Pubblicazione: (2025)
• Pharmacokinetics of subcutaneous and intravenous bolus doses of morphine in palliative care cancer patients receiving infusion of morphine: A pharmacokinetic substudy of a randomized controlled trial
  di: Eva Gravdahl, et al.
  Pubblicazione: (2025)